CRISPR Therapeutics AG
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | — | — | $945.0K |
| FY2015 | $124.0M | $159.4M | $156.0M |
| FY2016 | $112.1M | $345.0M | $315.5M |
| FY2017 | $83.5M | $271.3M | $239.8M |
| FY2018 | $96.8M | $489.0M | $456.6M |
| FY2019 | $127.3M | $1.07B | $943.8M |
| FY2020 | $163.7M | $1.83B | $1.17B |
| FY2021 | $352.4M | $2.75B | $923.0M |
| FY2022 | $367.6M | $2.24B | $211.9M |
| FY2023 | $346.8M | $2.23B | $389.5M |
| FY2024 | $310.0M | $2.24B | $298.3M |
| FY2025 | $343.4M | $2.27B | $347.6M |